Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 24.80
0.00 (0.00%)
At close: Apr 15, 2026
Biogened Market Cap
Biogened has a market cap or net worth of 60.92 million as of April 16, 2026. Its market cap has decreased by -2.36% in one year.
Market Cap
60.92M
Enterprise Value
78.84M
Revenue
114.04M
Ranking
n/a
PE Ratio
13.18
Stock Price
24.80
Market Cap Chart
Since August 31, 2011, Biogened's market cap has increased from 45.77M to 60.92M, an increase of 33.10%. That is a compound annual growth rate of 1.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 60.92M | 14.81% |
| Dec 30, 2025 | 53.06M | -6.09% |
| Dec 30, 2024 | 56.50M | 27.78% |
| Dec 29, 2023 | 44.21M | 41.73% |
| Dec 29, 2022 | 31.20M | 47.67% |
| Dec 30, 2021 | 21.12M | 1.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CDRL S.A. | 46.60M |
| Garin | 46.10M |
| Beskidzkie Biuro Inwestycyjne | 45.99M |
| Libet | 45.14M |
| MakoLab Spólka Akcyjna | 45.07M |
| Lokaty Budowlane | 44.52M |
| Herkules | 44.01M |
| Sygnis | 43.88M |